XRCC1 and lung carcinoma: Several previous published meta-analyses have been carried out to reveal the potential correlation of XRCC1 gene polymorphisms and platinum-based chemotherapy in lung cancer patients, these results remain conflicting rather than conclusive14, 15, 16, 79, 80, 81.